These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15190449

  • 1. [Management of chemotherapy induced diarrhea].
    Schultz M, Schölmerich J, Kullmann F.
    Z Gastroenterol; 2004 Jun; 42(6):527-38. PubMed ID: 15190449
    [Abstract] [Full Text] [Related]

  • 2. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
    Hoff PM, Saragiotto DF, Barrios CH, del Giglio A, Coutinho AK, Andrade AC, Dutra C, Forones NM, Correa M, Portella Mdo S, Passos VQ, Chinen RN, van Eyll B.
    J Clin Oncol; 2014 Apr 01; 32(10):1006-11. PubMed ID: 24516038
    [Abstract] [Full Text] [Related]

  • 3. Recommended guidelines for the treatment of chemotherapy-induced diarrhea.
    Wadler S, Benson AB, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E.
    J Clin Oncol; 1998 Sep 01; 16(9):3169-78. PubMed ID: 9738589
    [Abstract] [Full Text] [Related]

  • 4. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 01; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 5. [Chemotherapy-induced diarrhea].
    Kobayashi K.
    Gan To Kagaku Ryoho; 2003 Jun 01; 30(6):765-71. PubMed ID: 12852342
    [Abstract] [Full Text] [Related]

  • 6. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.
    Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST.
    Cancer Chemother Pharmacol; 2014 Oct 01; 74(4):675-80. PubMed ID: 25055935
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
    Saliba F, Hagipantelli R, Misset JL, Bastian G, Vassal G, Bonnay M, Herait P, Cote C, Mahjoubi M, Mignard D, Cvitkovic E.
    J Clin Oncol; 1998 Aug 01; 16(8):2745-51. PubMed ID: 9704727
    [Abstract] [Full Text] [Related]

  • 8. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
    Rosenoff SH.
    Eur J Cancer Care (Engl); 2004 Sep 01; 13(4):380-3. PubMed ID: 15305907
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
    Rosenoff SH, Gabrail NY, Conklin R, Hohneker JA, Berg WJ, Warsi G, Maloney J, Benedetto JJ, Miles EA, Zhu W, Anthony L.
    J Support Oncol; 2006 Jun 01; 4(6):289-94. PubMed ID: 16805331
    [Abstract] [Full Text] [Related]

  • 10. Neomycin as secondary prophylaxis for irinotecan-induced diarrhea.
    Schmittel A, Jahnke K, Thiel E, Keilholz U.
    Ann Oncol; 2004 Aug 01; 15(8):1296. PubMed ID: 15277273
    [No Abstract] [Full Text] [Related]

  • 11. High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.
    Cascinu S, Bichisao E, Amadori D, Silingardi V, Giordani P, Sansoni E, Luppi G, Catalano V, Agostinelli R, Catalano G.
    Support Care Cancer; 2000 Jan 01; 8(1):65-7. PubMed ID: 10650901
    [Abstract] [Full Text] [Related]

  • 12. Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
    Delaunoit T, Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Findlay BP, Thomas SP, Salim M, Schaefer PL, Stella PJ, Green E, Mailliard JA.
    Cancer; 2004 Nov 15; 101(10):2170-6. PubMed ID: 15470715
    [Abstract] [Full Text] [Related]

  • 13. Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment.
    Lenfers BH, Loeffler TM, Droege CM, Hausamen TU.
    Ann Oncol; 1999 Oct 15; 10(10):1251-3. PubMed ID: 10586346
    [Abstract] [Full Text] [Related]

  • 14. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
    Zidan J, Haim N, Beny A, Stein M, Gez E, Kuten A.
    Ann Oncol; 2001 Feb 15; 12(2):227-9. PubMed ID: 11300329
    [Abstract] [Full Text] [Related]

  • 15. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy.
    Gebbia V, Carreca I, Testa A, Valenza R, Curto G, Cannata G, Borsellino N, Latteri MA, Cipolla C, Florena M.
    Anticancer Drugs; 1993 Aug 15; 4(4):443-5. PubMed ID: 8400346
    [Abstract] [Full Text] [Related]

  • 16. Overview of chemotherapy-induced diarrhea.
    Viele CS.
    Semin Oncol Nurs; 2003 Nov 15; 19(4 Suppl 3):2-5. PubMed ID: 14702926
    [Abstract] [Full Text] [Related]

  • 17. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma.
    Topkan E, Karaoglu A.
    Oncology; 2006 Nov 15; 71(5-6):354-60. PubMed ID: 17873499
    [Abstract] [Full Text] [Related]

  • 18. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
    Farrell MP, Kummar S.
    Clin Colorectal Cancer; 2003 Feb 15; 2(4):253-6. PubMed ID: 12620148
    [No Abstract] [Full Text] [Related]

  • 19. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 15; 28(9):718-9. PubMed ID: 17274384
    [No Abstract] [Full Text] [Related]

  • 20. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
    Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kourousis C, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V.
    Dig Dis; 2007 Sep 15; 25(1):100-5. PubMed ID: 17384515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.